While antibiotic selection has been routinely used for the selection of genetically modi®ed cells, administration of cytotoxic drugs often leads to deleterious effects not only to inert cells but also to transfected or transduced ones. In this study, we propose an Antigen-MEdiated Genetically modi®ed cell Ampli®cation (AMEGA) system employing antibody/receptor chimeras without antibiotic selection. Based on a rational design where the extracellular domains of dimeric erythropoietin receptor (EpoR) or gp130 were substituted with heterodimeric V H /V L regions of anti-hen egg lysozyme (HEL) antibody and EpoR D2 domains, the genes encoding the chimeras as well as a model transgene, enhanced green¯uorescent protein (EGFP), were retrovirally infected into IL-3-dependent Ba/F3 cells followed by direct HEL selection in the absence of IL-3. After a single round of selection, EGFP-positive cells were selectively ampli®ed, resulting in a population of almost 100% positive cells. The AMEGA without antibiotic selection will not harm normal cells, which will be especially useful for increasing the ef®cacy for stem cell-based gene therapy.
INTRODUCTION
Selection of genetically modi®ed cells is a critical step to engineer the cells with desired properties. Antibiotic selection has been commonly used, which is based on the rescue of the transfectant in the presence of a cytotoxic drug and the selective deprivation of the non-transduced cells. However, the selection conditions such as initial cell density and drug concentration should be carefully determined since inappropriate conditions often lead to death of the transfectant or survival of the parental cells (1) . Furthermore, the growth rate is decreased even in the optimal concentration due to the cytotoxic drug (2, 3) . Such a selection procedure has some limitations for cells in which transduction ef®ciency is low and/or growth induction is dif®cult (1,4±6) .
To overcome these problems, we tried to create an arti®cial receptor that transduces a growth signal in response to a nontoxic substance. Co-expression of the arti®cial receptor and the gene of interest would result in a`growth advantage' only for genetically modi®ed cells by simply adding the non-toxic substance in the culture medium. We focused on an antigen± antibody system that has an in®nite number of combinations with high speci®city. In our previous study, the Fv region of anti-hen egg lysozyme (HEL) antibody HyHEL-10 was chosen as a model, since its V H -V L association is greatly enhanced with addition of HEL (7) , which is expected to be suitable for mimicry of ligand-induced dimerization of cytokine receptors in their activation (8, 9) . Thus, two chimeric erythropoietin receptors whose extracellular domain was replaced with either the V H or V L region of anti-hen egg lysozyme (HEL) antibody HyHEL-10 (HE or LE, respectively) were expressed in interleukin-3 (IL-3)-dependent hematopoietic cell lines, resulting in HEL-dependent cell growth without IL-3 (10) . This result demonstrates the utility of our antibody/receptor chimera for functional mimicry of cytokine receptors. In the following experiment, the cytoplasmic domains of HE and LE chimeric receptors were replaced with that of gp130 to create Hg and Lg chimeric receptors, respectively. Co-expression of Hg and Lg or Hg and LE resulted in HEL-dependent cell growth in factordependent cell lines (11, 12) . Furthermore, when the enhanced green¯uorescent protein (EGFP) was employed as a model transgene and placed downstream of the LE gene and the internal ribosomal entry site (IRES), HEL induced speci®c ampli®cation of the cells with high expression level of EGFP (13) . However, in all these studies, we used electroporation to transfect plasmids into the cells, which is not an ideal method for many applications due to relatively low transfection ef®ciency. In addition, in order to enrich the proportion of transfectants, antibiotic selection was always conducted prior to HEL selection, and the possibility of direct HEL selection was not pursued.
In this study, we employed a retroviral vector to attain higher transduction ef®ciency in a variety of cell types to expand the current approach. Whether or not the genetically modi®ed IL-3-dependent pro-B cells expressing the antibody/ receptor chimera could be directly ampli®ed by HEL selection immediately after retroviral infection was examined.
MATERIALS AND METHODS

Vector construction
The ecotropic retroviral vector pMX, and its derivatives pMX-GFP and pMXs-neo (14) , were kindly provided by Dr T. Kitamura (Institute of Medical Science, University of Tokyo). The construction of the HE chain gene encoding HyHEL-10 V H , a GSG linker, extracellular D2 and transmembrane/cytoplasmic domains of EpoR, and the LE chain gene encoding HyHEL-10 V L instead of V H in the HE chain, was described previously (10) . Construction of the Hg and Lg chain genes encoding the transmembrane and cytoplasmic domains of gp130 instead of those for HE and LE chains, respectively, was as described (11) . First, the`ampli®er' vectors were constructed. The Hg and Lg genes were digested from pME-Hg and pMEZ-Lg (11) with EcoRI, and ligated into EcoRI-digested pMX to obtain pMX-Hg and pMX-Lg, respectively. pME-HE (11) was digested with NcoI and XbaI to obtain the HE chain fragment, and inserted into NcoI and XbaI-digested pBSN, which is a variant of pBluescriptII SK(±) (Stratagene, La Jolla, CA) having a NcoI site between the SpeI and XbaI sites, in order to make a NotI site downstream of the HE gene, resulting in pBSN-HE. The HE gene fragment was digested from pBSN-HE with NcoI and NotI, and ligated into NcoI and NotI-digested pMX-Hg to produce pMX-HE. pMEZ-LE was digested with NcoI and SacII to obtain the V L fragment, and ligated into NcoI and SacII-digested pMX-HE to obtain pMX-LE. The`courier' vectors were constructed as follows. pMEZ-LEIGFP (13) was digested with XbaI to obtain the IRES-EGFP fragment, and inserted into a XbaI site of pBluescriptII SK(±) to produce pBS-IGFP. The IRES-EGFP fragment from pBS-IGFP was digested with NotI, and inserted into a NotI site of pMX-Hg and pMX-Lg to get pMX-HgIGFP and pMX-LgIGFP, which encode the IRES-EGFP cassette downstream of Hg and Lg, respectively. The LEIGFP fragment was digested from pMEZ-LEIGFP (13) with EcoRI and NotI, and inserted into EcoRI and NotI-digested pMX to create pMX-LEIGFP. To make a drug-resistant control vector, pMX-LgIGFP was digested with EcoRI and blunted with T4 DNA polymerase, followed by XhoI digestion to remove the Lg fragment. pMXsneo was digested with BglII and blunted, followed by SalI digestion to obtain the neomycin-resistance gene fragment. The fragment was inserted into the digested pMX-LgIGFP to obtain pMX-neoIGFP.
Cell culture
A murine IL-3-dependent pro-B cell line, Ba/F3 (15) , was cultured in RPMI 1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% FBS (Iwaki, Tokyo, Japan) and 2 ng/ml murine IL-3 (Genzyme/Techne, Cambridge, MA). A retroviral packaging cell line, Plat-E (16), was cultured in Dulbecco's modi®ed Eagle's medium (DMEM) (Nissui Pharmaceutical) supplemented with 10% FBS, 1 mg/ml puromycin (Sigma, St Louis, MO) and 10 mg/ml blasticidin (Kaken Pharmaceutical, Tokyo, Japan).
Retroviral infection and selection of the transfectants
Plat-E cells were inoculated into a 60 mm diameter dish at 5 Q 10 5 cells/ml in 4 ml DMEM, and cultured for 20 h. An aliquot of 9 ml Fugene6 (Roche Diagnostics, Basel, Switzerland) was diluted with 100 ml of serum-free F12 medium (Gibco BRL, Rockville, MD) and added to 3 mg of the retroviral vector solubilized in 6 ml of sterile water. After 15 min incubation at room temperature, the vector/Fugene6 mixture was added to the Plat-E cells. After 24 h incubation, the culture medium was refreshed with 4 ml DMEM, followed by an additional 24 h incubation. After the supernatant was centrifuged at 1000 g for 5 min at 20°C, Ba/F3 cells (10 5 cells) were infected with 500 ml of the viral supernatant in the presence of 10 mg/ml polybrene (Sigma) and 4 ng/ml IL-3 in 24-well plates. In the case of co-infection, 500 ml each of the viral supernatants was mixed and used to infect Ba/F3 cells. After 5 h incubation, the same volume of RPMI 1640 as the viral supernatant was added to reduce the toxicity of polybrene. The approximate multiplicity of infection (MOI) ranged from 1.0 to 4.2%, as estimated from the¯ow cytometric analysis on day 3 or 4 after infection. On day 6 or 7 after infection, the cells were washed with PBS once, and inoculated into 24-well plates at 2 Q 10 5 cells/ml. Selection was performed in the medium containing no factor, 1 mg/ml HEL (Seikagaku Corporation, Tokyo, Japan) or 2 ng/ml IL-3.
For the cloning experiment, cells before selection were washed with PBS once, and inoculated into 96-well plates at 5 Q 10 3 cells/ml (10 3 cells/well) with 1 mg/ml HEL. Parental Ba/F3 cells were washed with PBS three times and used to supplement each well at 10 5 cells/ml as feeder cells to effectively rescue limiting-diluted transfectant cells in their early growth phase. For comparison, retrovirally packaged pMX-neoIGFP was infected into Ba/F3 cells (MOI~35%), followed by inoculation into 96-well plates at 5 cells/ml (1 cell/ well) with 2 ng/ml IL-3 and 800 mg/ml G418 (Calbiochem, Darmstadt, Germany). Washed Ba/F3 cells (10 5 cells/ml) were used to supplement each well as feeders.
Western blotting
The cells (10 6 cells) were washed with PBS, lysed with 100 ml of lysis buffer [20 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin] and incubated on ice for 10 min. After centrifugation at 16 000 g for 5 min, the supernatant was mixed with Laemmli's sample buffer and boiled. The lysate was resolved by SDS±PAGE and transferred to a nitrocellulose membrane (Millipore, Bedford, MA). After the membrane was blocked with 5% skimmed milk, the blot was probed with 160 ng/ml of rabbit anti-mouse EpoR antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or 160 ng/ml of anti-mouse gp130 antibody (Santa Cruz Biotechnology) followed by 560 ng/ml of HRP-conjugated anti-rabbit IgG (Biosource, Camarillo, CA), and detection was e32 Nucleic Acids Research, 2003, Vol. 31, No. 7 performed using the ECL system (Amersham-Pharmacia, Little Chalfont, UK).
Cell proliferation assay
The HEL-selected cells were washed three times with PBS and seeded in 24-well plates containing various concentrations of HEL. The initial cell concentration was adjusted to 10 4 cells/ml. Cell number and viability were determined using a hemocytometer and the trypan blue exclusion assay.
Flow cytometry
Cells were washed with PBS and resuspended in Iso¯ow (Beckman Coulter, Fullerton, CA). Green¯uorescence intensity was measured using an EPICS-ALTRA¯ow cytometer (Beckman Coulter) at 488 nm excitation and¯uorescence detection at 525 T 20 nm.
RESULTS
Direct HEL selection ampli®ed the transfectants expressing chimeric receptors
We ®rst designed a selection scheme of the direct antigenmediated selection without the antibiotic selection step (Fig. 1 ). An`ampli®er' vector encodes a chimeric receptor gene, while a`courier' vector encodes the other partner of the functional chimeric receptor pair and an IRES-transgene cassette. The IRES sequence was used to couple a growth signal derived from chimeric receptors with transgene expression, since a correlation was observed between the expression levels of the two cistrons placed upstream and downstream of the IRES sequence (17, 18) . Therefore, transgene-expressing cells are expected to preferentially proliferate in the antigen-containing medium.
In this study, the EGFP gene was used as a model transgene, and an IRES-EGFP cassette was designated as IGFP. Four types of`ampli®er' vectors (pMX-HE, pMX-LE, pMX-Hg and pMX-Lg) and three types of`courier' vectors (pMX-LEIGFP, pMX-HgIGFP and pMX-LgIGFP) were constructed. IL-3-dependent Ba/F3 cells were infected with either one of the courier vectors or with one of the ampli®er±courier combinations, resulting in Ba/LEIGFP, Ba/HgIGFP, Ba/ LgIGFP, Ba/HgIGFP+Lg, Ba/HE+LgIGFP, Ba/Hg+LEIGFP and Ba/HgIGFP+LE cells. On day 6 or 7 after infection, the cells were washed with PBS once, and selected in the medium containing no factors, 1 mg/ml HEL or 2 ng/ml IL-3. Ba/ LEIGFP, Ba/HgIGFP and Ba/LgIGFP cells died immediately in the selection medium without IL-3 (data not shown), indicating that these courier vectors have no activity for selective ampli®cation of the transfectants on their own. On the other hand, all transfectants with ampli®er±courier combinations gave proliferating cells with HEL selection. Ba/ HgIGFP+Lg and Ba/HE+LgIGFP cells proliferate even without any factors, indicating the background growth-stimulating activity of the Hg+Lg and HE+Lg combinations.
To investigate whether cell proliferation in the selection medium with HEL or no factors was induced by the expressed chimeric receptors, cell lysates before and after the selection were prepared and the amounts of expressed chimeric receptors was compared by western blotting using anti-EpoR or anti-gp130 antibodies (Fig. 2) . In all ampli®er±courier combinations, IL-3-selected cells expressed~2-fold less amounts of chimeric receptors than the cells before selection. On the other hand, HEL-selected cells expressed considerably higher amounts of chimeric receptors than the cells before selection, indicating the ef®cient ampli®cation of the transduced cells over the non-transduced cells. Furthermore, Ba/ HgIGFP+Lg and Ba/HE+LgIGFP cells selected without any factors also expressed high amounts of chimeric receptors comparable to the HEL-selected cells, further con®rming the background growth signal from these chimeric receptor combinations. These results demonstrate the preferential ampli®cation of the transfectants expressing chimeric receptor combinations by direct HEL selection without antibiotic selection.
HEL selection induced selective expansion of EGFP-positive cells
To examine whether HEL selection induced selective expansion of the cells with transgene expression as well as chimeric receptor expression,¯ow cytometric analysis was performed to determine the EGFP-positive cell population before and after selection. On day 3 or 4 after infection, all the transfectants showed an EGFP-positive cell ratio of <5% (Figs 3±5). After IL-3 selection, the selected cells exhibited (Figs 3 and 4) . The EGFP-positive ratio was closely related to the expression level of the chimeric receptors, indicating ef®cient coupling of the two cistrons located upstream and downstream of the IRES sequence. These results clearly demonstrate that the chimeric receptorderived growth signal induced highly ef®cient ampli®cation of EGFP-positive cells.
HEL-dependent cell growth of the transfectants
To con®rm the characteristics of HEL-dependent cell growth of the transfectants after HEL selection, a cell proliferation assay of the transfectants was performed. Cells were washed and cultured in various concentrations of HEL. During the culture period, cell density and viability were measured. Ba/ HgIGFP+Lg cells showed HEL-dependent cell growth with a lower limit of 10 ng/ml, although considerable background growth without HEL was observed (Fig. 6 ). In the case of Ba/HE+LgIGFP cells, the lower limit of HEL-dependent cell growth was 1 ng/ml, which was most sensitive of all the ampli®er±courier combinations (Fig. 7) . However, Antigen-mediated expansion of the transfectants with chimeric receptor expression. The expression level of the chimeric receptor was compared before (bef.) and after (aft.) selection. Selection was performed in the culture medium containing either no factors (±), 1 mg/ml HEL or 2 ng/ml IL-3. pMX means Ba/F3 cells transfected with pMX vector without any inserts (named Ba/pMX) as a negative control. (A) Hg+Lg combinations, (B) HE+Lg combinations and (C) Hg+LE combinations were analyzed with anti-gp130 and anti-EpoR C-terminus antibodies. In each lane, cell lysate from 1.1 Q 10 5 cells was loaded. The actual dates for the harvest were as follows. In (A), day 6 for HgIGFP, Lg and HgIGFP+Lg bef.; day 39 for aft. (±) and HEL; day 36 for IL-3. In (B), day 7 for LgIGFP, HE and HE+LgIGFP bef.; day 67 for aft. (±); day 37 for HEL; day 56 for IL-3. In (C), day 6 for HgIGFP; day 7 for LEIGFP and Hg+LEIGFP bef.; day 40 for aft. HEL; day 56 for IL-3; day 6 for HgIGFP+LE bef.; day 39 for aft. HEL; day 36 for IL-3.
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background cell growth without HEL, which was less ef®cient than that induced by Hg+Lg combinations, was also observed. On the other hand, Ba/HgIGFP+LE and Ba/Hg+LEIGFP showed strict HEL-dependent cell growth without background growth (Fig. 8) . The lower limit of HEL required for growth was 10 ng/ml, although 1 ng/ml HEL showed some antiapoptotic effect. From these analyses, the Hg+LE combination was found to be the best one as an inducible selective ampli®er in Ba/F3 cells.
Comparison of the selection ef®ciency with antibiotic selection
To investigate the selection ef®ciency of our Antigen MEdiated Genetically modi®ed cell Ampli®cation (AMEGA) system, a cloning experiment was performed. Ba/HE+LgIGFP and Ba/ Hg+LEIGFP cells before selection were inoculated into two 96-well plates at a cell concentration of 10 3 cells/well. From the EGFP-positive cell ratio before selection, given that the gene transfer ef®ciencies of both courier and ampli®er vectors are the same, the populations of co-transfectants are calculated to be 0.036% (= 1.9% 2 ) and 0.01% (= 1.0% 2 ) for Ba/ HE+LgIGFP and Ba/Hg+LEIGFP cells, respectively. As shown in Table 1 , Ba/HE+LgIGFP and Ba/Hg+LEIGFP showed selection ef®ciencies of up to 30 and 26%. Although the values were not more than that with antibiotic selection of 45%, the data suggests that our AMEGA system could be almost as ef®cient as antibiotic selection as a selection method.
DISCUSSION
In this study, we have described an AMEGA system without any antibiotic selection steps. Antibiotic selection induces some deleterious effects such as growth inhibition (2, 3) , mutations in the antibiotic resistance gene and cell membrane permeability (19, 20) and morphological changes (21) . In contrast, in our system only one-step antigen selection resulted in 100% transgene-positive cells without any deleterious effects, indicating the utility of our method over conventional antibiotic selection. Compared with antibiotic selection, the selection ef®ciency of our AMEGA system was almost comparable. In addition, the AMEGA system could be potentially used for in vivo selection of transduced cells, which could not be attained by cytotoxic drug selection. We believe that this is a particular advantage of the AMEGA system, and that the selection ef®ciency of our system is suf®ciently high for practical use.
Whereas Ba/HgIGFP and Ba/LgIGFP cells did not exhibit background growth, Hg+Lg and HE+Lg combinations elicited some background growth without HEL, indicating preformed Hg-Lg or HE-Lg heterodimers in the transfectant expressing Hg+Lg or HE+Lg combinations, respectively. Although the background growth of the transfectant expressing Hg+Lg was observed in previous studies (11, 12) , the background growth of Ba/HE+LgIGFP was an unexpected ®nding, since the Hg+LE combination exhibited strict HEL-dependent cell growth. The distinct characteristics of Hg+LE and HE+Lg imply that the small conformational difference has an effect on signal transduction in the arti®cially induced EpoR-gp130 heterodimer. Recent X-ray crystallographic analyses revealed the importance of the conformation of the extracellular domain in EpoR signaling (8,9,22±24 ). In addition, recent studies using mutagenesis or chimeric receptors demonstrated the contribution of association between receptor transmembrane domains in EpoR signaling (25, 26) . In the model proposed in the study (26) , although EpoR takes two dimeric conformations with association in the extracellular domains or the transmembrane domains in the absence of Epo, the latter conformation is stabilized by Epo binding, thereby triggering signal transduction. Therefore, the different characteristics of Hg+LE and HE+Lg might imply that the stabilization effect of the transmembrane domain was changed by the extracellular construct of the chimera. The alteration to the mutated transmembrane domain with weaker association might realize more strictly regulated antigen-dependent cell ampli®cation (25±28).
Since antibiotic selection inhibits cell growth, it may take more time to select and expand the transfectant. The long selection period is problematic for the selection of primary culture cells, especially for the ones in which transduction ef®ciency is low, since the cells might be unexpectedly differentiated during the selection. In contrast, our method has the advantage that the cell growth could be rather stimulated. Stem cells, due to their pluripotency, are promising targets for gene therapy to correct various diseases (29±31). Since hematopoietic stem cells were reported to be expanded with gp130 and EpoR signaling (32, 33) , Hg+LE combinations might be applied to the ex vivo or in vivo ampli®cation of genetically modi®ed hematopoietic stem cells. Generalization of this approach including the use of other functional antigen±antibody pairs and alternative intracellular domains will provide wide applications of our selection system.
